HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Thomas K. Jones Flavian M. Lupinetti Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Starnes, S. L. Articles by Lupinetti, F. M. Search for Related Content PubMed PubMed Citation Articles by Starnes, S. L. Articles by Lupinetti, F. M.

J Thorac Cardiovasc Surg 2000;119:534-539
© 2000 Mosby, Inc.

SURGERY FOR CONGENITAL HEART DISEASE

VASCULAR ENDOTHELIAL GROWTH FACTOR AND BASIC FIBROBLAST GROWTH FACTOR IN CHILDREN WITH CYANOTIC CONGENITAL HEART DISEASE

From the Divisions of Cardiac Surgery^a and Cardiology,^b Children’s Hospital and Regional Medical Center, Seattle, Wash.

Address for reprints: Brian W. Duncan, MD, Division of Cardiac Surgery, Children’s Hospital and Regional Medical Center, 4800 Sand Point Way, NE, PO Box 5371/ CM-03, Seattle, WA 98105 (E-mail: bdunca{at}chmc.org ).

Objective: Vascular endothelial growth factor and basic fibroblast growth factor are potent stimulators of angiogenesis. Children with cyanotic congenital heart disease often experience the development of widespread formation of collateral blood vessels, which may represent a form of abnormal angiogenesis. We undertook the present study to determine whether children with cyanotic congenital heart disease have elevated serum levels of vascular endothelial growth factor and basic fibroblast growth factor.
Methods: Serum was obtained from 22 children with cyanotic congenital heart disease and 19 children with acyanotic heart disease during cardiac catheterization. Samples were taken from the superior vena cava, inferior vena cava, and a systemic artery. Vascular endothelial growth factor and basic fibroblast growth factor levels were measured in the serum from each of these sites by enzyme–linked immunosorbent assay.
Results: Vascular endothelial growth factor was significantly elevated in the superior vena cava (P = .04) and systemic artery (P = .02) but not in the inferior vena cava (P = .2) of children with cyanotic congenital heart disease compared to children with acyanotic heart disease. The mean vascular endothelial growth factor level, determined by averaging the means of all 3 sites, was also significantly elevated (P = .03). Basic fibroblast growth factor was only significantly elevated in the systemic artery (P = .02).
Conclusion: Children with cyanotic congenital heart disease have elevated systemic levels of vascular endothelial growth factor. These findings suggest that the widespread formation of collateral vessels in these children may be mediated by vascular endothelial growth factor.

This article has been cited by other articles:

				K. Suda, M. Matsumura, S. Miyanish, K. Uehara, T. Sugita, and M. Matsumoto Increased vascular endothelial growth factor in patients with cyanotic congenital heart diseases may not be normalized after a Fontan type operation Ann. Thorac. Surg., September 1, 2004; 78(3): 942 - 946. [Abstract] [Full Text] [PDF]

				A. Dodge-Khatami, N. Sreeram, B.A.J.M. de Mol, and G.B.W.E. Bennink Systemic plasma vascular endothelial growth factor levels as a marker for increased angiogenesis during the single ventricle surgical pathway Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 458 - 461. [Abstract] [Full Text] [PDF]

				B. W. Duncan and S. Desai Pulmonary arteriovenous malformations after cavopulmonary anastomosis Ann. Thorac. Surg., November 1, 2003; 76(5): 1759 - 1766. [Abstract] [Full Text] [PDF]

				Y. Ootaki, M. Yamaguchi, N. Yoshimura, S. Oka, M. Yoshida, and T. Hasegawa Vascular endothelial growth factor in children with congenital heart disease Ann. Thorac. Surg., May 1, 2003; 75(5): 1523 - 1526. [Abstract] [Full Text] [PDF]

				L. Lavie, H. Kraiczi, A. Hefetz, H. Ghandour, A. Perelman, J. Hedner, and P. Lavie Plasma Vascular Endothelial Growth Factor in Sleep Apnea Syndrome: Effects of Nasal Continuous Positive Air Pressure Treatment Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1624 - 1628. [Abstract] [Full Text] [PDF]

				S. L. Starnes, B. W. Duncan, J. M. Kneebone, G. L. Rosenthal, K. Patterson, C. H. Fraga, K. M. Kilian, S. K. Mathur, and F. M. Lupinetti Angiogenic proteins in the lungs of children after cavopulmonary anastomosis J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 518 - 523. [Abstract] [Full Text] [PDF]

				W. Jelkmann Pitfalls in the Measurement of Circulating Vascular Endothelial Growth Factor Clin. Chem., April 1, 2001; 47(4): 617 - 623. [Abstract] [Full Text] [PDF]